GlassScriptPrepare for your visit
Mahendra Narendran
Internal Medicine · Statesville, NC · NPI 1316074693
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$17,237.28
in general payments reported to CMS, 2019-2025 · $2,570 in 2025
The $2,570 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Who reported paying
General payments only, top 6 by amount.
- Novo Nordisk INC $1,720.94
- Astrazeneca Pharmaceuticals LP $1,582.52
- Pfizer INC. $1,531.24
- Abbvie INC. $1,161.73
- Boehringer Ingelheim Pharmaceuticals, INC. $1,127.96
- Lilly USA, LLC $1,086.97
Drugs and devices associated with these payments
Nurtec Odt Jardiance Rybelsus Ozempic Wegovy Repatha Otezla Farxiga Eliquis Mounjaro Vraylar Quviviq
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Mahendra Narendran listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/400007/mahendra-narendran